PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT 2.1 Preface 2.2 Preface 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE Market ecosystem Market characteristics Market segmentation analysis PART 04: MARKET SIZING Market definition Market sizing 2018 Market size and forecast 2018-2023 PART 05: FIVE FORCES ANALYSIS Bargaining power of buyers Bargaining power of suppliers Threat of new entrants Threat of substitutes Threat of rivalry Market condition PART 06: MARKET SEGMENTATION BY PRODUCT Market segmentation by product Comparison by product Renal dialysis devices - Market size and forecast 2018-2023 UI devices - Market size and forecast 2018-2023 Urolithiasis devices - Market size and forecast 2018-2023 BPH devices - Market size and forecast 2018-2023 Other devices - Market size and forecast 2018-2023 Market opportunity by product PART 07: CUSTOMER LANDSCAPE PART 08: GEOGRAPHIC LANDSCAPE Geographic segmentation Geographic comparison North America - Market size and forecast 2018-2023 Europe - Market size and forecast 2018-2023 Asia - Market size and forecast 2018-2023 ROW - Market size and forecast 2018-2023 Key leading countries Market opportunity PART 09: DECISION FRAMEWORK PART 10: DRIVERS AND CHALLENGES Market drivers Market challenges PART 11: MARKET TRENDS Rising demand for home dialysis treatment Increasing demand for sacral neuromodulation for UI Increasing demand for ureteroscopic lithotripsy PART 12: VENDOR LANDSCAPE Overview Landscape disruption PART 13: VENDOR ANALYSIS Vendors covered Vendor classification Market positioning of vendors B. Braun Melsungen AG Baxter BD Boston Scientific Corporation Fresenius Medical Care AG & Co. KGaA Olympus Corporation PART 14: APPENDIX Research methodology List of abbreviations PART 15: EXPLORE TECHNAVIO   Exhibit 01: Global medical devices market Exhibit 02: Segments of global medical devices market Exhibit 03: Market characteristics Exhibit 04: Market segments Exhibit 05: Market definition - Inclusions and exclusions checklist Exhibit 06: Market size 2018 Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions) Exhibit 08: Global market: Year-over-year growth 2019-2023 (%) Exhibit 09: Five forces analysis 2018 Exhibit 10: Five forces analysis 2023 Exhibit 11: Bargaining power of buyers Exhibit 12: Bargaining power of suppliers Exhibit 13: Threat of new entrants Exhibit 14: Threat of substitutes Exhibit 15: Threat of rivalry Exhibit 16: Market condition - Five forces 2018 Exhibit 17: Product - Market share 2018-2023 (%) Exhibit 18: Comparison by product Exhibit 19: Renal dialysis devices - Market size and forecast 2018-2023 ($ millions) Exhibit 20: Renal dialysis devices - Year-over-year growth 2019-2023 (%) Exhibit 21: UI devices - Market size and forecast 2018-2023 ($ millions) Exhibit 22: UI devices - Year-over-year growth 2019-2023 (%) Exhibit 23: Urolithiasis devices - Market size and forecast 2018-2023 ($ millions) Exhibit 24: Urolithiasis devices - Year-over-year growth 2019-2023 (%) Exhibit 25: BPH devices - Market size and forecast 2018-2023 ($ millions) Exhibit 26: BPH devices - Year-over-year growth 2019-2023 (%) Exhibit 27: Other devices - Market size and forecast 2018-2023 ($ millions) Exhibit 28: Other devices - Year-over-year growth 2019-2023 (%) Exhibit 29: Market opportunity by product Exhibit 30: Customer landscape Exhibit 31: Market share by geography 2018-2023 (%) Exhibit 32: Geographic comparison Exhibit 33: North America - Market size and forecast 2018-2023 ($ millions) Exhibit 34: North America - Year-over-year growth 2019-2023 (%) Exhibit 35: Europe - Market size and forecast 2018-2023 ($ millions) Exhibit 36: Europe - Year-over-year growth 2019-2023 (%) Exhibit 37: Asia - Market size and forecast 2018-2023 ($ millions) Exhibit 38: Asia - Year-over-year growth 2019-2023 (%) Exhibit 39: ROW - Market size and forecast 2018-2023 ($ millions) Exhibit 40: ROW - Year-over-year growth 2019-2023 (%) Exhibit 41: Key leading countries Exhibit 42: Market opportunity Exhibit 43: Unadjusted incidence rate of individuals who had commenced RRT for ESRD in 2015 (per 100,000 population) in various countries Exhibit 44: Impact of drivers and challenges Exhibit 45: Vendor landscape Exhibit 46: Landscape disruption Exhibit 47: Vendors covered Exhibit 48: Vendor classification Exhibit 49: Market positioning of vendors Exhibit 50: B. Braun Melsungen AG - Vendor overview Exhibit 51: B. Braun Melsungen AG - Business segments Exhibit 52: B. Braun Melsungen AG - Organizational developments Exhibit 53: B. Braun Melsungen AG - Geographic focus Exhibit 54: B. Braun Melsungen AG - Segment focus Exhibit 55: B. Braun Melsungen AG - Key offerings Exhibit 56: B. Braun Melsungen AG - Key customers Exhibit 57: Baxter - Vendor overview Exhibit 58: Baxter - Business segments Exhibit 59: Baxter - Organizational developments Exhibit 60: Baxter - Geographic focus Exhibit 61: Baxter - Segment focus Exhibit 62: Baxter - Key offerings Exhibit 63: Baxter - Key customers Exhibit 64: BD - Vendor overview Exhibit 65: BD - Business segments Exhibit 66: BD - Organizational developments Exhibit 67: BD - Geographic focus Exhibit 68: BD - Segment focus Exhibit 69: BD - Key offerings Exhibit 70: BD - Key customers Exhibit 71: Boston Scientific Corporation - Vendor overview Exhibit 72: Boston Scientific Corporation - Business segments Exhibit 73: Boston Scientific Corporation - Organizational developments Exhibit 74: Boston Scientific Corporation - Geographic focus Exhibit 75: Boston Scientific Corporation - Segment focus Exhibit 76: Boston Scientific Corporation - Key offerings Exhibit 77: Boston Scientific Corporation - Key customers Exhibit 78: Fresenius Medical Care AG & Co. KGaA - Vendor overview Exhibit 79: Fresenius Medical Care AG & Co. KGaA - Product segments Exhibit 80: Fresenius Medical Care AG & Co. KGaA - Organizational developments Exhibit 81: Fresenius Medical Care AG & Co. KGaA - Geographic focus Exhibit 82: Fresenius Medical Care AG & Co. KGaA - Segment focus Exhibit 83: Fresenius Medical Care AG & Co. KGaA - Key offerings Exhibit 84: Fresenius Medical Care AG & Co. KGaA - Key customers Exhibit 85: Olympus Corporation - Vendor overview Exhibit 86: Olympus Corporation - Business segments Exhibit 87: Olympus Corporation - Organizational developments Exhibit 88: Olympus Corporation - Geographic focus Exhibit 89: Olympus Corporation - Segment focus Exhibit 90: Olympus Corporation - Key offerings Exhibit 91: Olympus Corporation - Key customers Exhibit 92: Validation techniques employed for market sizing

B. Braun Melsungen AG Baxter BD Boston Scientific Corporation Fresenius Medical Care AG & Co. KGaA Olympus Corporation